2026-08390NoticeWallet

FDA Says Fenoglide Exit Wasn't Safety Scare – Generics Safe

Published Date: 4/30/2026

Notice

Summary

The FDA has confirmed that FENOGLIDE tablets (40 mg and 120 mg) were not taken off the market because of safety or effectiveness problems. This means generic drug makers can keep getting approval to sell their versions, keeping options open for patients and pharmacies. No changes in cost or availability are expected, so everyone can breathe easy!

Analyzed Economic Effects

3 provisions identified: 2 benefits, 1 costs, 0 mixed.

Generic Approvals May Continue

The FDA determined that FENOGLIDE (fenofibrate) tablets, 40 mg and 120 mg, were not withdrawn for reasons of safety or effectiveness. Because of that determination, the Agency will not begin procedures to withdraw approval of existing abbreviated new drug applications (ANDAs) that refer to this product, and additional ANDAs referring to the product may be approved if they meet legal and regulatory requirements.

Patient Access and Market Options Preserved

FDA confirmed FENOGLIDE (fenofibrate) tablets, 40 mg and 120 mg, were not removed for safety or effectiveness, and the product remains listed in the Orange Book's "Discontinued Drug Product List" as discontinued for reasons other than safety or effectiveness. The notice says FDA will continue to approve ANDAs that refer to this product when they meet requirements, so patients and pharmacies keep options for generic versions.

ANDA Applicants May Need Updated Labeling

The FDA said that if it determines labeling for FENOGLIDE should be revised to meet current standards, the Agency will advise ANDA applicants to submit such labeling. This informs generic applicants they may be asked to update labeling to conform with current requirements.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
4/30/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register